Amgen Newsroom

A Quick Look at Today's Ratings for Amgen(AMGN.US), With a Forecast Between $322 to $383

Futu NewsNov 1 21:21

Amgen Is Maintained at Neutral by UBS

Dow JonesNov 1 03:47

Amgen Analyst Ratings

BenzingaNov 1 03:38

Goldman Sachs Adjusts Price Target on Amgen to $375 From $369, Maintains Buy Rating

MT NewswiresOct 31 21:35

A Quick Look at Today's Ratings for Amgen(AMGN.US), With a Forecast Between $322 to $405

Futu NewsOct 31 21:18

Jefferies Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380

Futu NewsOct 29 20:33

RBC Capital Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $362

Futu NewsOct 28 19:35

Oppenheimer Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380

Futu NewsOct 25 20:35

Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $344

Futu NewsOct 23 20:31

Amgen (AMGN) Receives a Buy From Piper Sandler

TipRanksOct 23 19:45

Wells Fargo Maintains Amgen(AMGN.US) With Hold Rating, Maintains Target Price $335

Futu NewsOct 23 17:31

Bernstein Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380

Futu NewsOct 23 15:33

Navigating 14 Analyst Ratings For Amgen

BenzingaOct 23 03:02

Cantor Fitzgerald Reiterates Overweight on Amgen, Maintains $405 Price Target

BenzingaOct 22 23:13

TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Raises Target Price to $383

Futu NewsOct 21 19:34

Bernstein: First time covering eli lilly and co, gilead sciences and amgen, all with an "outperform large cap" rating.

Gelonghui FinanceOct 17 23:28

Amgen Analyst Ratings

BenzingaOct 17 19:34

Goldman Sachs Maintains Amgen(AMGN.US) With Buy Rating

Futu NewsOct 17 17:32

Bernstein begins to focus on US pharmaceutical stocks, rating eli lilly and co (LLY.US) and others as "outperforming large cap".

Zhitong FinanceOct 17 12:03

A Quick Look at Today's Ratings for Amgen(AMGN.US), With a Forecast Between $335 to $381

Futu NewsOct 16 21:04